Have you or a loved one taken these medications and been diagnosed with cancer?

The FDA issued its first voluntary recall of Valsartan in July 2018. Valsartan, a commonly prescribed drug for blood pressure, congestive heart failure (CHF), and diabetes, has been linked to containing several human carcinogens. In 2014, the manufacturing process for creating drugs containing Valsartan was changed. In doing so, manufacturers exposed the public to an increased risk of cancer. Zhejiang Huahai Pharmaceutical Co. of China has been the world’s leading manufacturer of Valsartan since 2012. The FDA throughout 2018 and the start of 2019 has issued updates and expanded its recall of the drug. The carcinogens in question are NDMA and NDEA, and now others. In early 2019, patients who had been taking the drug for some time started coming forward with diagnoses of cancer.

Valsartan has been linked to the following kinds of cancer:

  1. Liver Cancer
  2. Kidney Cancer
  3. Stomach Cancer
  4. Intestinal Cancer (including rectal and colon cancer)

The drug is also linked to high levels of liver damage. As a result of the FDA’s finding, over 20 countries around the world have recalled drugs with contaminated Valsartan. Today, many patients and their families are going through a very turbulent time. What was supposed to be a drug to treat a manageable condition like blood pressure, congestive heart failure, or diabetes may have led to impaired kidney or liver function, or worse—a diagnosis of cancer.

If you or a loved one were taking Valsartan starting in 2014, took the drug for at least one (1) year, and were diagnosed with cancer or impaired liver/kidney function, contact our law firm immediately.

There are important filing deadlines in order to preserve your potential claim. If you have been injured due to Valsartan, Losartan, or Irebesartan, let us hold these manufacturers responsible and work to get you the compensation that you and your family deserve.

Call us now: 1-877-650-6080 or email This email address is being protected from spambots. You need JavaScript enabled to view it..